Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Microsoft
MSFT
|
+$112M |
| 2 |
Ferguson
FERG
|
+$104M |
| 3 |
Amazon
AMZN
|
+$101M |
| 4 |
Apple
AAPL
|
+$98.3M |
| 5 |
International Flavors & Fragrances
IFF
|
+$75M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$52.5M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$38.1M |
| 5 |
Equity Residential
EQR
|
+$22.8M |
Sector Composition
| 1 | Technology | 25.7% |
| 2 | Healthcare | 14.14% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Communication Services | 10.9% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
International Bancshares
IBOC
$4.39B
| $5.71M | ﹤0.01% |
122,900
+1,000
| +0.8% | +$46.4K |
|
|
ARNC
1377
DELISTED
Arconic Corporation
ARNC
| $5.7M | ﹤0.01% |
224,400
+2,000
| +0.9% | +$50.8K |
|
1378
Axos Financial
AX
$5.17B
| $5.69M | ﹤0.01% |
121,100
| – | – |
|
1379
Nova
NVMI
$8.69B
| $5.68M | ﹤0.01% |
64,740
+821
| +1% | +$72K |
|
|
CCXI
1380
DELISTED
ChemoCentryx, Inc.
CCXI
| $5.67M | ﹤0.01% |
110,700
+1,700
| +2% | +$87.1K |
|
1381
Hamilton Lane
HLNE
$6.53B
| $5.65M | ﹤0.01% |
63,800
+4,500
| +8% | +$399K |
|
1382
Winnebago Industries
WGO
$949M
| $5.62M | ﹤0.01% |
73,300
+700
| +1% | +$53.7K |
|
1383
First Bancorp
FBP
$3.49B
| $5.61M | ﹤0.01% |
498,600
+4,200
| +0.8% | +$47.3K |
|
1384
Ligand Pharmaceuticals
LGND
$3.23B
| $5.61M | ﹤0.01% |
58,990
+641
| +1% | +$61K |
|
|
ITCI
1385
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.59M | ﹤0.01% |
164,800
+3,700
| +2% | +$126K |
|
|
RCM
1386
DELISTED
R1 RCM Inc. Common Stock
RCM
| $5.59M | ﹤0.01% |
226,600
+4,500
| +2% | +$111K |
|
1387
Forward Air
FWRD
$904M
| $5.59M | ﹤0.01% |
62,900
-500
| -0.8% | -$44.4K |
|
|
RETA
1388
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.58M | ﹤0.01% |
56,000
+1,100
| +2% | +$110K |
|
1389
Moog
MOG.A
$6.27B
| $5.58M | ﹤0.01% |
67,100
-900
| -1% | -$74.8K |
|
|
MIME
1390
DELISTED
Mimecast Limited
MIME
| $5.57M | ﹤0.01% |
138,600
+3,000
| +2% | +$121K |
|
1391
Apellis Pharmaceuticals
APLS
$3.14B
| $5.57M | ﹤0.01% |
129,800
+1,600
| +1% | +$68.7K |
|
1392
Viasat
VSAT
$4.1B
| $5.56M | ﹤0.01% |
115,724
+1,300
| +1% | +$62.5K |
|
1393
MillerKnoll
MLKN
$1.4B
| $5.54M | ﹤0.01% |
134,600
+1,400
| +1% | +$57.6K |
|
1394
WesBanco
WSBC
$3.03B
| $5.54M | ﹤0.01% |
153,545
+1,600
| +1% | +$57.7K |
|
1395
Gentherm
THRM
$1.06B
| $5.54M | ﹤0.01% |
74,700
+800
| +1% | +$59.3K |
|
|
KC
1396
Kingsoft Cloud Holdings
KC
$4.45B
| $5.53M | ﹤0.01% |
140,716
+14,500
| +11% | +$570K |
|
1397
John Wiley & Sons Class A
WLY
$2.19B
| $5.52M | ﹤0.01% |
101,900
+800
| +0.8% | +$43.4K |
|
1398
Methanex
MEOH
$3.04B
| $5.5M | ﹤0.01% |
149,000
+1,800
| +1% | +$66.4K |
|
1399
MaxLinear
MXL
$1.37B
| $5.49M | ﹤0.01% |
160,973
+3,900
| +2% | +$133K |
|
1400
Murphy Oil
MUR
$3.68B
| $5.47M | ﹤0.01% |
333,400
+2,700
| +0.8% | +$44.3K |
|